Jane Street’s GenMark Diagnostics, Inc GNMK Stock Holding History

Jane Street’s Portfolio GNMK Stock Details GNMK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-34,700	Closed	-$829K	–	10852
2021 Q1	$829K	Buy	34,700 +19,100	+122%	+$355K	﹤0.01%	5824
2020 Q4	$228K	Sell	15,600 -2,200	-12%	-$29.2K	﹤0.01%	6787
2020 Q3	$253K	Sell	17,800 -24,800	-58%	-$379K	﹤0.01%	6125
2020 Q2	$627K	Buy	+42,600	New	+$433K	﹤0.01%	4731

Jane Street's GNMK Position: Q2 2021 in Review

Jane Street sold out of GenMark Diagnostics, Inc (GNMK) in Q2 2021, closing a stake of 57,610 shares — an estimated $1.38M sold.

Jane Street first reported a position in GNMK in Q4 2013 and held it in 6 quarters. The position peaked at $1.38M in Q1 2021. 0 funds tracked by Wall St. Rank hold GNMK as of Q2 2021.

Jane Street reported no remaining GenMark Diagnostics, Inc position as of Q2 2021 after selling out during the quarter.
Jane Street sold 57,610 GenMark Diagnostics, Inc shares in Q2 2021, an estimated $1.38M.
Jane Street first reported a position in GenMark Diagnostics, Inc in Q4 2013 and held it in 6 quarters.
Jane Street's GenMark Diagnostics, Inc position peaked at $1.38M in Q1 2021.
0 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q2 2021.

Based on Jane Street's 13F filing for Q2 2021, filed 16 Aug 2021.